GMED | GLOBUS MEDICALNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$79.58
+$0.12 (+0.15%)

GLOBUS MEDICAL (GMED) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat below the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the weekly, price sits between the 50 and the 200; on the 4-hour it is above both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $79.58 vs 50 $77.38 / 200 $83.35
Projection
No cross projected
Test
No active test
Last cross
Death cross 8 Jul 2026 ยท projected 26 bars out ยท tested 3 bars

Weekly as of 30 Oct 16:00 ET

Price
between the two $78.05 vs 50 $84.31 / 200 $68.51
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 9 Dec 2024 ยท projected 23 bars out

Cross history

30
crosses on record since 2017
14 golden16 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
16 Sep 2026Death4-hour30 bars outNot tested
28 Aug 2026Golden4-hour28 bars out2 bar cross test
8 Jul 2026Death moderatedaily26 bars out3 bar cross test
14 May 2026Death4-hour28 bars outNot tested
22 Apr 2026Golden4-hour21 bars out1 bar cross test

About GMED

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$101M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.